Featured Cancer Videos |view more
As M. Sean Grady, Chairman, Department of Neurosurgery, explains, when patients are faced with a malignant brain tumor, a second opinion from the specialists at the Penn Brain Tumor Center can confirm or clarify the initial diagnosis and, ...
The Penn Brain Tumor Center offers patients access to innovative advances in treatment -- including immunotherapy -- through personalized clinical trials.
With specialized training and knowledge of cancer diagnoses, treatments and health system operations, Penn Neuro-Onc Nurse Navigators act as a patient’s primary contact during their course of care.
The Tumor Board at the Penn Brain Center includes a multidisciplinary clinical and research team that meets weekly to review new brain tumor cases and to consider current cases that present challenges.
Dr. Mark O’Hara of the Abramson Cancer Center discusses checkpoint inhibition in the context of pancreatic cancer in this presentation from the Abramson Cancer Center’s Immunology and Immunotherapy for Pancreatic Cancer Symposium.
In this engaging presentation, he describes the current strategies and evolving immunotherapies for pancreatic cancer and their potential to improve both the standards of care and the outcomes for the disease.
Featured Articles |view more
Researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone.
Clinical Briefing - Endocrine and Oncologic Surgery, April 24, 2018
Penn Medicine News